期刊文献+

糖尿病足的血管介入治疗18例体会

Clinical Effect of Interventional Therapy in 18 Cases of Diabetic Foot
原文传递
导出
摘要 目的:探讨糖尿病足腔内血管介入治疗的可行性。方法:18例糖尿病足患者,Fontaine分期:Ⅱb期6例,Ⅲ期9例,Ⅳ期3例,术前行多普勒彩超、CT血管造影(CTA)或磁共振血管造影(MRA)检查,选择顺或逆行股动脉穿刺,数字减影动脉造影(DSA)机下行下肢动脉包括膝下动脉经皮腔内血管成形(PTA)+支架成形术。结果:18例病人技术成功率100%,保肢率100%,下肢皮温变暖,行走功能明显改善。结论:腔内血管介入治疗因为微创、可重复性强、病人身体条件易承受、保肢率高,应成为恢复糖尿病足缺血血供的首选治疗手段。 Objective: To study the clinical effect of interventional therapy on diabetic foot.Methods: Eighteen patients with diabetic foot,including 6 cases in Ⅱb period,9 cases in Ⅲ period,and 3 cases in Ⅳ period according to the Fontaine staging,were underwent color Doppler ultrasound,CTA,or MRA examination before operation.All the patients were carried out PTA or stent-implantation on arteries of lower extremity including inferior genicular arteries under DSA guidance.Results: The technical successful rate was 100%,and the ratio of extremity protecting was 100% with warmer skin and better walking function.Conclusion: Interventional therapy is important for the treatment of diabetic foot,because it is a micro-trauma and reliable method,and is more acceptable for patients,and has a higher rate for extremity protecting.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2009年第5期680-682,共3页 Medical Journal of Wuhan University
关键词 糖尿病足 血管腔内 介入治疗 Diabetes Foot Intracavitary Blood Vessel Interventional Therapy
  • 相关文献

参考文献5

  • 1吴在德,吴肇汉.外科学[M].第6版.人民卫生出版社,2003,628-629.
  • 2Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment[J]. Foot Ankle, 1981,2 (2) : 64- 122.
  • 3常宝成,潘从清,曾淑范.糖尿病足的诊断和治疗[J].国外医学(内分泌学分册),2002,22(1):25-28. 被引量:84
  • 4刘克辉,王铁军,刘青,谷贵山.53例糖尿病足临床特点分析[J].中国实验诊断学,2006,10(9):1088-1089. 被引量:2
  • 5Boyko EJ, Ahroni JH, Stensel V, et al. A prospective study of risk factors for diabetic foot ulcer. The seattle diabetic foot study[J]. Diabetes Care, 1999,22 (7): 1 036-1 042.

二级参考文献28

  • 1糖尿病足(肢端坏疽)检查方法及诊断标准(草案)[J].中国糖尿病杂志,1996,4(2):126-126. 被引量:593
  • 2Boulton A J. The diabetic foot: a global view[J]. Diabetes Metab Res Rev,2000,16(suppl 1):S2-S5.
  • 3Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot?[J]. Diabetes Metab Res Rev,2000,16:S75-S83.
  • 4Lavery L A, Armstrong D G, Harkless L B. Classification of diabetic foot wounds[J]. J Foot Ankle Surg,1996,35:528-531.
  • 5Pham H, Armstrong D G, Harvey C, et al. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial[J]. Diabetes Care,2000,23:606-611.
  • 6Sauseng S, Kastenbauer T, Sokol G, et al. Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy[J]. Diabetes Nutr Metab,1999,12:189-193.
  • 7Boykin J V Jr. The nitric oxide connection: hyperbaric oxygen therapy, becaplermin, and diabetic ulcer management[J]. Adv Skin Wound Care,2000,13:169-174.
  • 8Holstein P E, Sorensen S. Limb salvage experience in a multidisciplinary diabetic foot unit[J]. Diabetes Care,1999,22:B97-B103.
  • 9Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia[J]. Circulation, 1998,97:1114-1123.
  • 10Hissink R J, Manning H A, van Baal J G. The MABAL shoe, an alternative method in contact casting for treatment of neuropathic diabetic foot ulcers[J]. Foot Ankle Int,2000,21:320-323.

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部